Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multi-parametric MRI without artificial erection for preoperative assessment of primary penile carcinoma: A pilot study on the correlation between imaging and histopathological findings.
Switlyk MD, Hopland A, Sivanesan S, Brennhovd B, Ottosson F, Berner K, Axcrona U, Hole KH. Switlyk MD, et al. Among authors: sivanesan s. Eur J Radiol Open. 2023 Jan 28;10:100478. doi: 10.1016/j.ejro.2023.100478. eCollection 2023. Eur J Radiol Open. 2023. PMID: 36793771 Free PMC article.
Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer.
Guldvik IJ, Braadland PR, Sivanesan S, Ramberg H, Kristensen G, Tennstedt P, Røder A, Schlomm T, Berge V, Eri LM, Lilleby W, Mills IG, Taskén KA. Guldvik IJ, et al. Among authors: sivanesan s. Eur Urol Open Sci. 2022 Oct 4;45:68-75. doi: 10.1016/j.euros.2022.09.002. eCollection 2022 Nov. Eur Urol Open Sci. 2022. PMID: 36353660 Free PMC article.
Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore.
Lim EH, Lim A, Khara JS, Cheong J, Fong J, Sivanesan S, Griffiths M, New E, Lee SC. Lim EH, et al. Among authors: sivanesan s. Expert Rev Pharmacoecon Outcomes Res. 2024 Mar;24(3):413-426. doi: 10.1080/14737167.2023.2295474. Epub 2024 Jan 30. Expert Rev Pharmacoecon Outcomes Res. 2024. PMID: 38289042
Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients: Rationale and design of the LEGACY study.
van der Sangen NMR, Küçük IT, Sivanesan S, Appelman Y, Ten Berg JM, Verburg A, Azzahhafi J, Arkenbout EK, Kikkert WJ, Pisters R, Jukema JW, Arslan F, van 't Hof A, Ilhan M, Hoebers LP, van der Schaaf RJ, Damman P, Woudstra P, van de Hoef TP, Bax M, Anthonio RL, Polad J, Adriaenssens T, Dewilde W, Zivelonghi C, Laanmets P, Majas R, Dijkgraaf MGW, Claessen BEPM, Henriques JPS. van der Sangen NMR, et al. Among authors: sivanesan s. Am Heart J. 2023 Nov;265:114-120. doi: 10.1016/j.ahj.2023.07.011. Epub 2023 Jul 28. Am Heart J. 2023. PMID: 37517430 Free article. Clinical Trial.
Author Correction: Pcyt2 deficiency causes age-dependent development of nonalcoholic steatohepatitis and insulin resistance that could be attenuated with phosphoethanolamine.
Grapentine S, Singh RK, Basu P, Sivanesan S, Mattos G, Oresajo O, Cheema J, Demeke W, Dolinsky VW, Bakovic M. Grapentine S, et al. Among authors: sivanesan s. Sci Rep. 2023 Jun 22;13(1):10175. doi: 10.1038/s41598-023-36725-w. Sci Rep. 2023. PMID: 37349480 Free PMC article. No abstract available.
147 results